Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk's Ozempic, a head-to-head study published Monday showed. Most patients achieved five percent or greater weight loss after a year, but those on Mounjaro were more likely to lose weight and achieved greater weight loss.
